Speaker illustration

Doctor Ana Marcano

Bellvitge University Hospital, Hospitalet De Llobregat (Spain)

Lack of impact on responsiveness to clopidogrel and aspirin of improving glycaemic control in patients with type 2 diabetes mellitus and stable coronary artery disease on dual antiplatelet therapy

Event: ESC Congress 2017

Topic: Diabetes, dysglycaemia and metabolic syndrome

Session: Diabetes


Greater pharmacodynamic efficacy of ticagrelor compared to clopidogrel in patients with diabetes mellitus and stable coronary artery disease: a randomized investigation

Event: ESC Congress 2017

Topic: Thrombosis and coagulation

Session: Antithrombotic strategies in coronary artery disease


Underuse of more potent P2Y12 antagonists in elderly patients, despite having worse response to clopidogrel compared to younger patients

Event: ESC Congress 2016

Topic: Elderly and cardiovascular diseases

Session: Are we better at managing cardiovascular disease in the elderly?


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb